Indole derivatives as cGMP-PDE inhibitors

PCT No. PCT/JP96/00892 Sec. 371 Date Dec. 10, 1997 Sec. 102(e) Date Dec. 10, 1997 PCT Filed Apr. 2, 1996 PCT Pub. No. WO96/32379 PCT Pub. Date Oct. 17, 1996Compounds of the formula (I): and their pharmaceutically acceptable compositions are useful in inhibiting the activity of cyclic guanosine 3...

Full description

Saved in:
Bibliographic Details
Main Authors SOGABE; KEIZO, SAWADA; KOZO, KURODA; AKIO, HOSOGAI; NAOMI, KOBAYASHI; MASAKAZU, NAGASHIMA; AKIRA, NOMOTO; ATSUSHI, NAKAJIMA; YOSHIMITSU, OKU; TERUO, OHNE; KAZUHIKO, TAMURA; KOUICHI
Format Patent
LanguageEnglish
Published 30.05.2000
Edition7
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:PCT No. PCT/JP96/00892 Sec. 371 Date Dec. 10, 1997 Sec. 102(e) Date Dec. 10, 1997 PCT Filed Apr. 2, 1996 PCT Pub. No. WO96/32379 PCT Pub. Date Oct. 17, 1996Compounds of the formula (I): and their pharmaceutically acceptable compositions are useful in inhibiting the activity of cyclic guanosine 3',5'-monophosphate phosphodiesterase.
Bibliography:Application Number: US19970930597